Trials / Completed
CompletedNCT02971930
Exit Interviews to Assess Impact of Infusion Frequency in Hemophilia A
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is to generate qualitative data to evaluate the impact of frequency of FVIII infusions on patients' satisfaction with treatment and their quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | BAY94-9027 | Intravenous infusion of BAY94-9027 |
Timeline
- Start date
- 2017-06-20
- Primary completion
- 2017-11-26
- Completion
- 2017-12-15
- First posted
- 2016-11-23
- Last updated
- 2018-02-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02971930. Inclusion in this directory is not an endorsement.